Estrade
  • Finance
  • Real Estate
  • Tech
  • Education
  • Lifestyle & Leisure
  • Estrade Awards
No Result
View All Result
Estrade
  • Finance
  • Real Estate
  • Tech
  • Education
  • Lifestyle & Leisure
  • Estrade Awards
No Result
View All Result
Estrade
No Result
View All Result
Home Hot News

Sunflower Therapeutics Completes Major Installation of Daisy Petal™ Systems at the Serum Institute of India, the World’s Largest Vaccine Manufacturer

Team Estrade by Team Estrade
December 4, 2025
in Hot News, Technology
0
Sunflower Therapeutics Completes Major Installation of Daisy Petal™ Systems at the Serum Institute of India, the World's Largest Vaccine Manufacturer
Share on FacebookShare on Twitter

Daisy Petal™ systems installed in GMP space to enable perfusion fermentation at SIIPL, enabling faster, higher-yield protein production in a compact, user-friendly platform

Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, today announced that it has completed the sale and installation of several Daisy Petal™ Perfusion Bioreactor Systems at the Serum Institute of India Pvt. Ltd. (SIIPL), part of Cyrus Poonawalla Group, the world’s largest vaccine manufacturer. The installation marks the largest deployment of the Daisy Petal ™ to date, highlighting the growing global adoption of perfusion fermentation in commercial vaccine manufacturing.

Sunflower’s innovative Daisy Petal™ perfusion fermentation system is a breakthrough technology that uses a single-use assembly designed specifically for intuitive installation and a simple user experience. The system’s hardware and controls are engineered and optimized for in-vessel perfusion utilizing a disposable stirred tank reactor outfitted with a unique in-vessel cell retention device that enables greater volumetric productivity from the bench through scale-up manufacturing. With this approach, the system boasts space-time yield benefits five-to-ten times greater compared to traditional fed-batch fermentation methods for the production of diverse proteins.

“Completing this installation at the Serum Institute of India is a pivotal moment for Sunflower and for global vaccine accessibility,” said Dr. Kerry R. Love, Founder, CEO, and President of Sunflower Therapeutics. “The Daisy Petal™ offers a path to clinical biomanufacturing in a system dramatically smaller than conventional bioreactors. Its patented technology and automated, user-friendly platform enable companies like SIIPL to unlock the advantages of perfusion fermentation, accelerating high-quality protein production and expanding access to life-saving vaccines worldwide.”

Related Post

Tenthpin Launches AI, IoMT-based Centre for Life Sciences Innovation Hub in Bengaluru

Tenthpin Management Consultants: Launches AI and IoMT Life Sciences Innovation Hub in Bengaluru

September 18, 2026
IDTA Members Invest Approximately INR 2,170 Crores Across 56 Deep-Tech Companies in Alliance's First Year

India Deep Tech Alliance: Invests INR 2,170 Crores in 56 Deep-Tech Companies

September 18, 2026

Chandigarh University: Biotechnology Students Secure 178 Placements

July 30, 2026

DNP: Establishes Second Overseas R&D Base in India

March 23, 2026

Sunflower’s bioprocessing software suite, compliant with Good Manufacturing Practices (GMP) for use in regulated biomanufacturing, includes HelianthOS™, Nursery™, and Harvest™. These tools enable walkaway automation of fermentation processes, easy development of process recipes with no coding, and the secure storage of process data generated by the Daisy Petal™ System. Together, these three elements provide a cohesive ecosystem that enables efficient and intuitive operations throughout an entire campaign.

To learn more about the Daisy Petal™, please visit sunflowertx.com .

About Sunflower Therapeutics

Sunflower Therapeutics is a unique biotech with a mission to transform bioeconomies worldwide by creating accessible solutions for protein product development and commercial manufacturing. Using our core technologies – an efficient host, data-driven methods for process development, and continuous biomanufacturing equipment – our team aims to democratize bioprocessing.

Source: Business Wire India

Donation

Buy author a coffee

Donate
Tags: bioreactorsbiotechnologyhealthcare technologyperfusion fermentationpharmaceuticalsprotein productionvaccine manufacturing
Team Estrade

Team Estrade

Related Posts

Tenthpin Launches AI, IoMT-based Centre for Life Sciences Innovation Hub in Bengaluru
Spotlight

Tenthpin Management Consultants: Launches AI and IoMT Life Sciences Innovation Hub in Bengaluru

by Team Estrade
September 18, 2026
IDTA Members Invest Approximately INR 2,170 Crores Across 56 Deep-Tech Companies in Alliance's First Year
Finance

India Deep Tech Alliance: Invests INR 2,170 Crores in 56 Deep-Tech Companies

by Team Estrade
September 18, 2026
Chandigarh University's Biotechnology & Pharmacy Students Secure 178 Placements with Leading Pharmaceutical and Biotechnology Companies
Education

Chandigarh University: Biotechnology Students Secure 178 Placements

by Team Estrade
July 30, 2026
Next Post
Vrutti Partners with HSBC India to Launch 'FPO Shakti', a Financing Facility to Strengthen Farmer Producer Organisations

Vrutti Partners with HSBC India to Launch 'FPO Shakti', a Financing Facility to Strengthen Farmer Producer Organisations

Recommended

Innoviti Receives ASK Private Hurun India Unicorn & Future Unicorn Award (PRNewsfoto/Innoviti Technologies Pvt. Ltd.)

Innoviti Receives ASK Private Hurun India Unicorn & Future Unicorn Award

December 18, 2025

Ebix Inc.: Joins NeoProEd Insurance Conclave as Gold Partner in GIFT City

September 21, 2026
India's First Women's Pro Volleyball League Builds Squads with Rs 1.5 Crore Investment

Women’s Pro Volleyball League: Launches with Rs 1.5 Crore Player Investment

October 26, 2026
Noida Expressway Emerges As Ncr Apos S Fastest Growing Luxury Housing Corridor

ANAROCK: Noida Expressway Redefines Luxury Living

June 10, 2026
SPJIMR #2 in India and #15 globally in Financial Times

S.P. Jain Institute of Management & Research (SPJIMR): Ranks No. 42 in The Case Centre Impact Index 2026

November 2, 2026
CRIF Launches Ahmedabad Chapter of ‘Credit Goes to HER’ to Advance Women’s Financial Empowerment

CRIF: Launches Ahmedabad Chapter of Credit Goes to HER for Women’s Financial Empowerment

November 2, 2026
Deakin University and CHL partner with IIT Roorkee

IIT Roorkee and Deakin University: Launch Crisis Leadership Training

November 2, 2026
30 Sundays Releases Insights on How Bali Travel Has Changed for Indian Couples

30 Sundays: Indian Couples Shift to Split Stays and Island Overnights in Bali

November 2, 2026
Estrade

We are a business news focused digital platform. Our vision is to provide a stage to businesses and corporate houses who are on a growth trajectory.

Get in Touch : info@estrade.in

Stay ahead with Estrade Business Media

Get the latest in business!


    Categories

    • Education
    • Finance
    • Hot News
    • Lifestyle & Leisure
    • Real Estate
    • Spotlight
    • Technology

    © 2025 Estrade | Engineered by WEBINEERING.

    No Result
    View All Result
    • Finance
    • Real Estate
    • Tech
    • Education
    • Lifestyle & Leisure
    • Estrade Awards

    © 2025 Estrade | Engineered by WEBINEERING.